{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:20:14Z","timestamp":1777087214186,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019550","name":"SPARC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/02\/2020-Nan\/BMS"],"award-info":[{"award-number":["45\/02\/2020-Nan\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bmcl.2025.130135","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:09:15Z","timestamp":1739491755000},"page":"130135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identifying thiourea-based hybrids of quinazoline and oxospirochromane as inhibitors of Plasmodium cysteine proteases arresting the parasitic growth at the early trophozoite stage"],"prefix":"10.1016","volume":"120","author":[{"given":"Abdur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimin D.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat C.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazia","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohasib Yusub","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Heyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari","family":"Madhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahim","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarosh S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-2056","authenticated-orcid":false,"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130135_b0005","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.bmcl.2025.130135_b0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2025.130135_b0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2025.130135_b0020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2025.130135_b0025","unstructured":"WHO, World Malaria Report 2022, WHO Team, 2022., 20222. https:\/\/www.who.int\/pub lications-detail-redirect\/9789240064898."},{"key":"10.1016\/j.bmcl.2025.130135_b0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130135_b0035","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(19)30394-9","article-title":"Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia","volume":"19","author":"M\u00e9nard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130135_b0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (MosquirixTM): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bmcl.2025.130135_b0045","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1097\/MS9.0000000000001648","article-title":"Breaking the malaria barrier: the WHO-approved R21\/Matrix-M vaccine and its global impact \u2013 an editorial","volume":"86","author":"Verma","year":"2024","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.bmcl.2025.130135_b0050","doi-asserted-by":"crossref","unstructured":"Rosenthal PJ, Falcipains and other cysteine proteases of malaria parasites, in: 2011: pp. 30\u201348. doi: 10.1007\/978-1-4419-8414-2_3.","DOI":"10.1007\/978-1-4419-8414-2_3"},{"key":"10.1016\/j.bmcl.2025.130135_b0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/156802612799362913","article-title":"Falcipain inhibition as a promising antimalarial target","volume":"12","author":"Marco","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0060","doi-asserted-by":"crossref","unstructured":"Patrick GL, Falcipains as drug targets in antimalarial therapy, in: Antimalar. Agents, Elsevier, 2020: pp. 271\u2013317. doi: 10.1016\/B978-0-08-101210-9.00008-1.","DOI":"10.1016\/B978-0-08-101210-9.00008-1"},{"key":"10.1016\/j.bmcl.2025.130135_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/np8003529","article-title":"Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A","volume":"72","author":"Linington","year":"2009","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2025.130135_b0070","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1021\/jm501439w","article-title":"Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials","volume":"57","author":"Conroy","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0075","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1021\/acs.jmedchem.9b00504","article-title":"Falcipain inhibitors based on the natural product gallinamide A are potent in vitro and in vivo antimalarials","volume":"62","author":"Stoye","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1590\/S0036-46652014000100006","article-title":"In vitro antigiardial activity of the cysteine protease inhibitor E-64","volume":"56","author":"de Carvalho","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.bmcl.2025.130135_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00394","article-title":"Structural insights into key plasmodium proteases as therapeutic drug targets","volume":"10","author":"Mishra","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2025.130135_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115564","article-title":"Development of diphenylmethylpiperazine hybrids of chloroquinoline and triazolopyrimidine using Petasis reaction as new cysteine proteases inhibitors for malaria therapeutics","volume":"258","author":"Madhav","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115155","article-title":"Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity","volume":"28","author":"Rana","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104514","article-title":"Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: design, synthesis and antimalarial efficacy studies","volume":"108","author":"Singh","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmcl.2025.130135_b0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","article-title":"An overview of quinazolines: Pharmacological significance and recent developments","volume":"151","author":"Alagarsamy","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0115","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2025.130135_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria box: A drug discovery catalyst for neglected diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2025.130135_b0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/jm00211a020","article-title":"Quantitative structure-activity relation of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines","volume":"20","author":"Hansch","year":"1977","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0130","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1021\/jo990877k","article-title":"Catalytic asymmetric synthesis of antimalarial alkaloids febrifugine and isofebrifugine and their biological activity","volume":"64","author":"Kobayashi","year":"1999","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0135","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1073\/pnas.1205414109","article-title":"Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum","volume":"109","author":"Malmquist","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2025.130135_b0140","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/acs.jmedchem.2c02092","article-title":"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4","volume":"66","author":"Ashton","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0145","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.ejmech.2009.06.001","article-title":"Search for new pharmacophores for antimalarial activity. Part III: Synthesis and bioevaluation of new 6-thioureido-4-anilinoquinazolines\u2606","volume":"44","author":"Mishra","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0150","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"Synthesis and structure\u2212activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0155","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.bmc.2005.02.037","article-title":"Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives","volume":"13","author":"Chiyanzu","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0160","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1016\/j.ejmech.2011.06.021","article-title":"Targeting the human malaria parasite Plasmodium falciparum: In vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series","volume":"46","author":"Castera-Ducros","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0165","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1016\/j.bmcl.2011.06.113","article-title":"4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum","volume":"21","author":"Verhaeghe","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130135_b0170","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.3390\/molecules25173929","article-title":"Synthesis and antiplasmodial evaluation of 4-carboxamido- and 4-alkoxy-2-trichloromethyl quinazolines","volume":"25","author":"Amrane","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130135_b0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejmech.2016.09.029","article-title":"Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold","volume":"125","author":"Desroches","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01804-18","article-title":"Evaluation of 4-amino 2-anilinoquinazolines against plasmodium and other apicomplexan parasites in vitro and in a P. falciparum humanized NOD-scid IL2R\u03b3 null mouse model of malaria","volume":"63","author":"Gilson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130135_b0185","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1021\/acs.jmedchem.0c00829","article-title":"Opportunities for tapping into three-dimensional chemical space through a quaternary carbon","volume":"63","author":"Talele","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0190","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0195","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.bmcl.2014.06.081","article-title":"The use of spirocyclic scaffolds in drug discovery","volume":"24","author":"Zheng","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130135_b0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.jmedchem.0c01473","article-title":"Spirocyclic scaffolds in medicinal chemistry","volume":"64","author":"Hiesinger","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for Falciparum and vivax malaria","volume":"371","author":"White","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2025.130135_b0210","doi-asserted-by":"crossref","unstructured":"Rottmann M, McNamara C, Yeung BKS, et al., Spiroindolones, a potent compound class for the treatment of malaria, Science (80-.). 329 (2010) 1175\u20131180. doi: 10.1126\/science.1193225.","DOI":"10.1126\/science.1193225"},{"key":"10.1016\/j.bmcl.2025.130135_b0215","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.02225-13","article-title":"Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130135_b0220","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciab716","article-title":"Efficacy of cipargamin (KAE609) in a randomized, phase II dose-escalation study in adults in Sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria","volume":"74","author":"Schmitt","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130135_b0225","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1016\/j.bmc.2015.02.050","article-title":"Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents","volume":"23","author":"Meyers","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpddr.2016.02.004","article-title":"Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages","volume":"6","author":"Roberts","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmcl.2025.130135_b0235","doi-asserted-by":"crossref","first-page":"24725","DOI":"10.1039\/D4RA04370G","article-title":"Sulfonamide based pyrimidine derivatives combating Plasmodium parasite by inhibiting falcipains-2 and falcipains-3 as antimalarial agents","volume":"14","author":"Rahman","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2025.130135_b0240","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/jm00164a005","article-title":"Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators","volume":"33","author":"Bergmann","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0245","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.bmcl.2008.09.065","article-title":"Synthesis and free radical scavenging activity of some new spiropyranocoumarins","volume":"18","author":"Panteleon","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130135_b0250","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.3390\/molecules200916221","article-title":"Synthesis, biological evaluation and molecular docking studies of piperidinylpiperidines and spirochromanones possessing quinoline moieties as acetyl-CoA carboxylase inhibitors","volume":"20","author":"Huang","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130135_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103086","article-title":"Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents","volume":"90","author":"Hu","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0260","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.tetlet.2008.03.045","article-title":"A new efficient synthesis of isothiocyanates from amines using di-tert-butyl dicarbonate","volume":"49","author":"Munch","year":"2008","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2025.130135_b0265","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02781-21","article-title":"Bazedoxifene, a postmenopausal drug, acts as an antimalarial and inhibits hemozoin formation","volume":"10","author":"Sudhakar","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bmcl.2025.130135_b0270","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/iai.63.6.2120-2125.1995","article-title":"Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase","volume":"63","author":"Salas","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.bmcl.2025.130135_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3201\/eid0401.980107","article-title":"Proteases of malaria parasites: new targets for chemotherapy","volume":"4","author":"Rosenthal","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130135_b0280","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.chembiol.2012.09.020","article-title":"The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains","volume":"19","author":"Stolze","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130135_b0285","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/AAC.40.7.1600","article-title":"Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors","volume":"40","author":"Rosenthal","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130135_b0290","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2002-01-0101","article-title":"Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development","volume":"100","author":"Hanspal","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bmcl.2025.130135_b0295","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/febs.14130","article-title":"Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation","volume":"284","author":"Deu","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.bmcl.2025.130135_b0300","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/AAC.00022-06","article-title":"Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin","volume":"50","author":"Parikh","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130135_b0305","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1039\/C5NJ01408E","article-title":"Novel stereoselective 2,3-disubstituted quinazoline-4(3H)-one derivatives derived from glycine as a potent antimalarial lead","volume":"39","author":"Patel","year":"2015","journal-title":"New J Chem"},{"key":"10.1016\/j.bmcl.2025.130135_b0310","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.bmc.2019.06.038","article-title":"Green synthesis, biological evaluation, molecular docking studies and 3D-QSAR analysis of novel phenylalanine linked quinazoline-4(3H)-one-sulphonamide hybrid entities distorting the malarial reductase activity in folate pathway","volume":"27","author":"Patel","year":"2019","journal-title":"Bioorg Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T09:05:16Z","timestamp":1741511116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":62,"alternative-id":["S0960894X25000447"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130135","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying thiourea-based hybrids of quinazoline and oxospirochromane as inhibitors of Plasmodium cysteine proteases arresting the parasitic growth at the early trophozoite stage","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130135"}}